- Home
- VERU vs DIT Comparison
VERU vs DIT Comparison
Compare VERU & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- DIT
- Stock Information
- Founded
- VERU 1971
- DIT 1981
- Country
- VERU United States
- DIT United States
- Employees
- VERU N/A
- DIT N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- DIT Food Distributors
- Sector
- VERU Health Care
- DIT Consumer Discretionary
- Exchange
- VERU Nasdaq
- DIT Nasdaq
- Market Cap
- VERU 76.9M
- DIT 78.7M
- IPO Year
- VERU 1990
- DIT 1995
- Fundamental
- Price
- VERU $0.50
- DIT $116.00
- Analyst Decision
- VERU Strong Buy
- DIT
- Analyst Count
- VERU 2
- DIT 0
- Target Price
- VERU $4.00
- DIT N/A
- AVG Volume (30 Days)
- VERU 856.5K
- DIT 207.0
- Earning Date
- VERU 05-08-2025
- DIT 07-17-2025
- Dividend Yield
- VERU N/A
- DIT 0.65%
- EPS Growth
- VERU N/A
- DIT N/A
- EPS
- VERU N/A
- DIT 2.44
- Revenue
- VERU $16,886,419.00
- DIT $2,221,421,072.00
- Revenue This Year
- VERU N/A
- DIT N/A
- Revenue Next Year
- VERU N/A
- DIT N/A
- P/E Ratio
- VERU N/A
- DIT $46.26
- Revenue Growth
- VERU 134.43
- DIT 7.47
- 52 Week Low
- VERU $0.45
- DIT $99.87
- 52 Week High
- VERU $1.42
- DIT $166.00
- Technical
- Relative Strength Index (RSI)
- VERU 44.61
- DIT 50.56
- Support Level
- VERU $0.48
- DIT $111.56
- Resistance Level
- VERU $0.56
- DIT $113.42
- Average True Range (ATR)
- VERU 0.02
- DIT 2.24
- MACD
- VERU -0.00
- DIT 0.13
- Stochastic Oscillator
- VERU 30.83
- DIT 60.04
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About DIT AMCON Distributing Company
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores, and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.